Azienda Ospedaliera Universitaria Integrata Verona

Verona, Verona 37126

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Hemophilia B, Hemophilia a

Studies at this site

• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B — Stopped early